Co-Founder & Chief Scientific Officer

Chief Financial Officer

Edgewise Therapeutics to Present on Sevasemten for Becker and Duchenne Muscular Dystrophies at the 30th International Annual Congress of the World Muscle Society

Edgewise Therapeutics reports inducement grants as permitted by Nasdaq listing rules

Goldman Sachs assigns Neutral rating to Edgewise Therapeutics

Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules

Director/Senior Director, Regulatory Project Manager

Edgewise Therapeutics is on a mission to discover new medicines that improve the lives of patients facing serious muscle disease. The Director/Senior Director, Regulatory Project Manager will support the regulatory affairs team to ensure appropriate planning, cross program coordination, and regulatory milestone readiness.

Sign up with Google

Sign in with Google